FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Deighan

Research Profile

Disorders

Procedures

Chemicals & Drugs

Living Beings

Physiology

Phenotype

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Shona Methven; Denis Stj O'Reilly; Jamie P Traynor; Christopher J Deighan; Mark S Macgregor
Urine albumin:protein ratio as a predictor of patient outcomes in CKD.
Samira Bell; Muriel J Caslake; Josephine Cooney; Christopher J Packard; Christopher J Deighan
The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria.
S Methven; Jamie P Traynor; D St J O'Reilly; Christopher J Deighan; M D Hair; M S MacGregor
Stratifying risk in chronic kidney disease: an observational study of UK guidelines for measuring total proteinuria and albuminuria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Deighan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Shona Methven; Denis Stj O'Reilly; Jamie P Traynor; Christopher J Deighan; Mark S Macgregor
Urine albumin:protein ratio as a predictor of patient outcomes in CKD.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(8):3372-3; author reply 3373-4.
2012: Samira Bell; Muriel J Caslake; Josephine Cooney; Christopher J Packard; Christopher J Deighan
The effect of omega-3 fatty acids on the atherogenic lipoprotein phenotype in patients with nephrotic range proteinuria.
Clinical nephrology 2012;77(6):445-53.
2011: S Methven; Jamie P Traynor; D St J O'Reilly; Christopher J Deighan; M D Hair; M S MacGregor
Stratifying risk in chronic kidney disease: an observational study of UK guidelines for measuring total proteinuria and albuminuria.
QJM : monthly journal of the Association of Physicians 2011;104(8):663-70.
2011: Shona Methven; Mark MacGregor; Jamie P Traynor; Mario Hair; Denis St J O'Reilly; Christopher J Deighan
Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(1):21-8.
2010: Shona Methven; Mark MacGregor; Jamie P Traynor; Denis St J O'Reilly; Christopher J Deighan
Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratio.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(9):2991-6.
2010: T A Collidge; S Razvi; C Nolan; M Whittle; C Stirling; A J C Russell; A C Mann; Christopher J Deighan
Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
Diabetic medicine : a journal of the British Diabetic Association 2010;27(6):696-700.
2010: S Bell; Christopher J Deighan
The conundrum of statins in chronic kidney disease.
Scottish medical journal 2010;55(1):30-3.
2009: Samira Bell; Josephine Cooney; Christopher J Packard; Muriel J Caslake; Christopher J Deighan
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria.
Atherosclerosis 2009;205(1):296-301.
2008: Bruce Mackinnon; Christopher J Deighan; William R Ferrell; Naveed Sattar; Jonathan G Fox
Endothelial function in patients with proteinuric primary glomerulonephritis.
Nephron. Clinical practice 2008;109(1):c40-7.
2007: Annette V M Alfonzo; Keith Simpson; Christopher J Deighan; Stewart Campbell; Jonathan Fox
Modifications to advanced life support in renal failure.
Resuscitation 2007;73(1):12-28.
2006: Annette V M Alfonzo; Chris Isles; Colin Geddes; Christopher J Deighan
Potassium disorders--clinical spectrum and emergency management.
Resuscitation 2006;70(1):10-25.
2005: Samira Siddiqui; Mark MacGregor; Catherine Glynn; Giles Roditi; Christopher J Deighan
Factors predicting outcome in a cohort of patients with atherosclerotic renal artery disease diagnosed by magnetic resonance angiography.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(6):1065-73.
2005: Majid Malekzadeh Shafaroudi; Melissa McBride; Christopher J Deighan; Alexis Wokoma; Joyce Macmillan; Craig J Daly; John C McGrath
Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium.
The Journal of pharmacology and experimental therapeutics 2005;314(2):804-10.
2005: John C McGrath; Christopher J Deighan; Ana M Briones; Majid Malekzadeh Shafaroudi; Melissa McBride; Jeremy Adler; Silvia M Arribas; Elisabet Vila; Craig J Daly
New aspects of vascular remodelling: the involvement of all vascular cell types.
Experimental physiology 2005;90(4):469-75.
2005: John Sharp; Matt R Wild; Andrew I Gumley; Christopher J Deighan
A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(6):1046-57.
2005: Bruce Mackinnon; Christopher J Deighan; J Norrie; J Michael Boulton-Jones; N Sattar; Jonathan G Fox
The link between circulating markers of endothelial function and proteinuria in patients with primary glomerulonephritis.
Clinical nephrology 2005;63(3):173-80.
2005: Christopher J Deighan; Laura Methven; Mustafa M Naghadeh; Alexis Wokoma; Joyce Macmillan; Craig J Daly; Akito Tanoue; Gozoh Tsujimoto; John C McGrath
Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice.
British journal of pharmacology 2005;144(4):558-65.
2005: Samira Siddiqui; David Kavanagh; Jamie Traynor; May Mak; Christopher J Deighan; Colin Geddes
Risk factors for restless legs syndrome in dialysis patients.
Nephron. Clinical practice 2005;101(3):c155-60.
2005: Mark MacGregor; Christopher J Deighan; R Stuart C Rodger; J Michael Boulton-Jones
A prospective open-label randomised trial of quinapril and/or amlodipine in progressive non-diabetic renal failure.
Nephron. Clinical practice 2005;101(3):c139-49.
2004: Christopher J Deighan; Alison M Woollhead; Janet F Colston; John C McGrath
Hepatocytes from alpha1B-adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution.
British journal of pharmacology 2004;142(6):1031-7.
2004: Jamie P Traynor; Keith Simpson; Colin C Geddes; Christopher J Deighan; Jonathan G Fox
Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(4):1009; author reply 1010.
2004: Nicola Joss; C Ferguson; C Brown; Christopher J Deighan; KR Paterson; J Michael Boulton-Jones
Intensified treatment of patients with type 2 diabetes mellitus and overt nephropathy.
QJM : monthly journal of the Association of Physicians 2004;97(4):219-27.
2003: Bruce Mackinnon; L Shakerdi; Christopher J Deighan; Jonathan G Fox; Denis St J O'Reilly; Michael Boulton-Jones
Urinary transferrin, high molecular weight proteinuria and the progression of renal disease.
Clinical nephrology 2003;59(4):252-8.
2002: Jamie P Traynor; Keith Simpson; Colin C Geddes; Christopher J Deighan; Jonathan G Fox
Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure.
Journal of the American Society of Nephrology : JASN 2002;13(8):2125-32.
2002: Craig J Daly; Christopher J Deighan; Ann McGee; Dawson Mennie; Zeeshan Ali; Melissa McBride; John C McGrath
A knockout approach indicates a minor vasoconstrictor role for vascular alpha1B-adrenoceptors in mouse.
Physiological genomics 2002;9(2):85-91.
2002: Nicola Joss; KR Paterson; Christopher J Deighan; Keith Simpson; J Michael Boulton-Jones
Diabetic nephropathy: how effective is treatment in clinical practice?
QJM : monthly journal of the Association of Physicians 2002;95(1):41-9.
2001: Christopher J Deighan; Muriel J Caslake; M McConnell; J Michael Boulton-Jones; Chris J Packard
The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria.
Atherosclerosis 2001;157(1):211-20.
2001: Michael J Zuscik; Dan Chalothorn; D Hellard; Christopher J Deighan; Ann McGee; Craig J Daly; DJ Waugh; Sean A Ross; Robert J Gaivin; Annitta J Morehead; James David Thomas; Edward F Plow; John C McGrath; Michael T Piascik; Dianne M Perez
Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the alpha 1B-adrenergic receptor.
The Journal of biological chemistry 2001;276(17):13738-43.
2001: Christopher J Deighan; Muriel J Caslake; M McConnell; J Michael Boulton-Jones; Chris J Packard
Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease.
Journal of the American Society of Nephrology : JASN 2001;12(2):341-8.
2000: Christopher J Deighan; Muriel J Caslake; M McConnell; J Michael Boulton-Jones; Chris J Packard
Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1.
Kidney international 2000;58(3):1238-46.
2000: Christopher J Deighan; Muriel J Caslake; M McConnell; J Michael Boulton-Jones; Chris J Packard
Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(5):852-62.
1998: Christopher J Deighan; Muriel J Caslake; M McConnell; J Michael Boulton-Jones; Chris J Packard
Increased atherogenicity of low-density lipoprotein in heavy proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(5):1183-8.